UNSPSC 51391716: Divabuterol

This classification denotes a bronchodilator, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BVG9H4U2ZB. European Medicines Agency schedules Divabuterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06337MIG. Divabuterol generally arises in the molecular formula C22H35NO5.

UNSPSC 51391716 Divabuterol is a Commodity code that covers pharmaceutical products for respiratory and related medical use, but the recent state and local solicitation activity under this code does not reflect divabuterol procurement. Instead, Seminole County, Florida posted an IFB (IFB60459723LAS) in June 2026 seeking naloxone and safe drug deactivation systems—products outside the nominal scope of the code. The mismatch between the code's stated product line and the actual solicitation suggests either a tagging error in the source data or that this code is being applied inconsistently by the issuing jurisdiction. No additional state or local opportunities supporting genuine divabuterol procurement appear in the recent activity block.

Seminole County's naloxone and drug deactivation systems bid (due July 26, 2023, with a response deadline of 2:00 pm) called for 1,900 units of naloxone and 800 deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract includes a two-year initial term with a one-year renewal option, drug-free workplace and E-Verify compliance requirements, and standard insurance coverage mandates. The procurement appears to carry FEMA funding implications, introducing federal compliance obligations around the Clean Air Act and Federal Water Pollution Control Act. Because the code shows minimal recent activity aligned with its nominal scope, prospective vendors should verify current tagging practices with Seminole County or other Florida jurisdictions before committing resources to pursuit under this code classification.